The newly cleared capability uses AI through the smartSET pulse oximetry sensor platform.

On 22 June 2026, Masimo, a Danaher company, received FDA 510(k) clearance for an AI-enabled opioid-induced respiratory ...

Masimo smartSET™-powered, AI-enabled OIRD detection has received FDA 510(k) clearance for the Radius VSM® wearable continuous ...

Irvine-based Masimo, which was acquired by Danaher, has received FDA clearance for a monitor feature to detect opioid-induced ...

Remote and continuous patient monitoring is moving from a niche capability to a core pillar of modern healthcare, driven by aging populations, staffing shortages, and a push toward data-driven care ...

Masimo’s family of continuous and spot-check monitoring Pulse CO-Oximeters ® includes devices designed for use in a variety of clinical and non-clinical scenarios, including tetherless, wearable ...

The life sciences giant is transforming its diagnostics segment with its acquisition of Masimo Corporation, shifting from ...

IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI), a global leader in noninvasive monitoring technologies, today announced the full U.S. market release of the Stork smart home baby monitoring ...

LiDCO Offers Clinicians, for the First Time, a Board-in-Cable Solution Designed to Provide a More Complete Picture of Oxygen Delivery NEUCHATEL, Switzerland--(BUSINESS WIRE)-- Masimo (NASDAQ: MASI) ...

(RTTNews) - Masimo Corporation (MASI) Monday said it received clearance from the Food and Drug Administration (FDA) for its over-the-counter monitoring system Stork for babies up to 18 months. Stork ...

The Stork system centers around a flexible, medical-grade silicone boot that straps to a baby’s foot and is embedded with a sensor for continuous measurement of their blood oxygen saturation, pulse ...